| Literature DB >> 32499596 |
Abdulraouf Lamoshi1, Jerrold Lerman2,3, Jad Dughayli2,3, Valerie Elberson4, Lorin Towle-Miller5, Gregory E Wilding5, David H Rothstein2,6.
Abstract
PURPOSE: The purpose of this study is to determine factors associated with prolonged intubation after inguinal herniorrhaphy in neonates.Entities:
Mesh:
Year: 2020 PMID: 32499596 PMCID: PMC7270742 DOI: 10.1038/s41372-020-0703-4
Source DB: PubMed Journal: J Perinatol ISSN: 0743-8346 Impact factor: 3.225
Demographics and preoperative comorbidities of GA and CA groups.
| Variable | GA | CA | |
|---|---|---|---|
| Adjusted age at time of surgery | 42.3 Weeks | 39.1 Weeks | 0.76 |
| Weight at time of surgery | 3.2 kg | 2.5 kg | 0.07 |
| PHT | 10 (11.8%) | 1 (8.3%) | 1.00 |
| BPD | 55 (64.7%) | 7 (58.3%) | 0.75 |
| RDS | 61 (73.5%) | 7 (58.3%) | 0.31 |
| ORD | 58 (68.2%) | 7 (58.3%) | 0.52 |
| Major CHD | 7 (8.2%) | 0 (0%) | 0.59 |
| Minor CHD | 67 (78.8%) | 7 (58.3%) | 0.15 |
| Prior intubation | 67 (79.8%) | 9 (75%) | 0.71 |
| Muscle relaxants use | 13 (17.8%) | 0 (0%) | 0.35 |
| Opioid use | 74 (87.1%) | 10 (83.3%) | 0.66 |
| Neonatal apnea | 59 (69.4%) | 6 (50%) | 0.20 |
| Ongoing apnea | 58 (68.2%) | 6 (50%) | 0.33 |
| Anemia | 78 (91.8%) | 12 (100%) | 0.59 |
| Steroids use | 62 (72.9%) | 8 (66.7%) | 0.73 |
| Renal problems | 43 (50.6%) | 5 (41.7%) | 0.76 |
| Liver problems | 65 (76.5%) | 11 (91.7%) | 0.45 |
BPD bronchopulmonary dysplasia, CA caudal anesthesia, CHD congenital heart disease, GA general anesthesia, ORD other respiratory disorders, PHT pulmonary hypertension, RDS respiratory distress syndrome.
Demographics and preoperative comorbidities of prolonged and short-no intubation groups.
| Variable | PIG | SNIG | |
|---|---|---|---|
| Adjusted age at time of surgery | 41.8 Weeks | 42.0 Weeks | 0.53 |
| Weight at time of surgery | 3.2 kg | 3.1 kg | 0.08 |
| PHT | 6 (21.4%) | 4 (7.0%) | 0.07 |
| BPD | 23 (82.1%) | 32 (56.1%) | |
| RDS | 22 (84.6%) | 39 (68.4%) | 0.18 |
| ORP | 23 (82.1%) | 35 (61.4%) | 0.08 |
| Major CHD | 4 (14.3%) | 3 (5.3%) | 0.21 |
| Minor CHD | 23 (82.1%) | 44 (77.2%) | 0.78 |
| Prior intubation | 26 (92.9%) | 41 (73.2%) | |
| Muscle relaxants use | 2 (7.7%) | 11 (23.4%) | 0.12 |
| Opioid use | 27 (96.4%) | 47 (82.5%) | 0.09 |
| Neonatal apnea | 20 (71.4%) | 39 (68.4%) | 1.00 |
| Ongoing apnea | 19 (67.9%) | 39 (68.4%) | 1.00 |
| Anemia | 28 (100%) | 50 (87.7%) | 0.09 |
| Steroids use | 22 (78.6%) | 40 (70.2%) | 0.45 |
| Renal problems | 18 (64.3%) | 25 (43.9%) | 0.11 |
| Liver problems | 24 (85.7%) | 41 (71.9%) | 0.19 |
| Preoperative FiO2 | 51.0 | 29.2 | |
| Postoperative FiO2 | 36.9 | 30.7 |
BPD bronchopulmonary dysplasia, CHD congenital heart disease, ORD other respiratory disorders, PHT pulmonary hypertension, PIG prolonged intubation group, RDS respiratory distress syndrome, SNIG short-no intubation group, P-values in bold indicate statistically significant results.